子痫前期预防的最佳证据总结

doi:10.3761/j.issn.1672-9234.2024.01.014

摘要/Abstract

摘要：

目的总结子痫前期预防的最佳证据。方法系统检索国内外决策支持系统、数据库及指南或专业协会网站中关于子痫前期预防的文献，检索时限为2013年1月—2023年1月，文献类型包括临床决策、指南、最佳实践、证据总结、系统评价、专家共识。由2名研究者独立筛选文献、提取资料并对纳入文献的方法学质量进行评价后，对证据进行提取、质量分级及汇总。结果共纳入24篇文献，其中临床决策2篇、指南8篇、专家共识3篇、系统评价11篇。从风险因素、风险评估时机与方法、血压监测与管理、药物预防、非药物预防、健康教育6个方面总结出21条关于子痫前期预防的最佳证据。结论本研究总结了子痫前期预防的最佳证据。医护人员应结合临床情境、孕妇意愿，审慎地选择与运用证据，以早期甄别高危孕妇，并指导其早期开展子痫前期预防工作，进而降低其子痫前期的发生风险，促进母婴安全。

关键词: 妊娠, 子痫前期, 预防, 循证护理学, 证据总结

Abstract:

Objective To search and summarize the best evidence of preeclampsia prevention in pregnant women. Methods The relevant evidence of preeclampsia prevention in pregnant women was systematically searched from domestic and foreign databases. The retrieval time was from June 1, 2013 to June 1, 2023. Clinical decisions, guidelines, evidence summaries, systematic evaluations and expert consensuses were included. Two researchers independently screened literature, extracted data, and evaluated the quality of the included literature. The evidence was extracted from the included literature and summarized after its quality was graded. Results A total of 24 articles were enrolled, including two clinical decision, eight guidelines, three expert consensuses, and 11 systematic reviews. Then 21 pieces of evidence were summarized, including risk factors, timing and tools for risk factor assessment, blood pressure monitoring and management, drug prevention, non-drug prevention, and health education. Conclusion This study summarized the measures to prevent preeclampsia for pregnant women. Evidence should be carefully selected in combination with the clinical situation in China and the wishes of pregnant women, so as to early identify high-risk pregnant women and carry out early prevention, so as to reduce the risk of preeclampsia and promote the safety of mother and child.

Key words: Pregnancy, Preeclampsia, Prevention, Evidence-Based Nursing, Summary of evidence

蒲丛珊, 杨依云, 孔肖楠, 单春剑, 夏家爱, 张翔娣, 朱珠, 龙伟, 王义婷. 子痫前期预防的最佳证据总结[J]. 中华护理教育, 2024, 21(1): 81-88.

PU Congshan, YANG Yiyun, KONG Xiaonan, SHAN Chunjian, XIA Jiaai, ZHANG Xiangdi, ZHU Zhu, LONG Wei, WANG Yiting. Best evidence summary for prevention of preeclampsia[J]. Chinese Journal of Nursing Education, 2024, 21(1): 81-88.

图/表 4

参考文献 41

[1]	谢幸, 孔北华, 段涛. 妇产科学[M]. 9版. 北京: 人民卫生出版社, 2018:84.
[2]	谢芳, 张晓燕, 苏敏, 等. 子痫前期不良妊娠结局的影响因素和风险预测模型建立与验证[J]. 重庆医科大学学报, 2022, 47(12):1400-1406.
	Xie F, Zhang XY, Su M, et al. Establishment and verification of influencing factors and risk prediction model of adverse pregnancy outcome in pre-eclampsia[J]. J Chongqing Med Univ, 2022, 47(12):1400-1406.
[3]	Yu H, Li W, Mao ZX, et al. Association between hypertensive disorders during pregnancy and elevated blood pressure in offspring:a systematic review and meta-analysis[J]. J Clin Hypertens (Greenwich), 2022, 24(11):1397-1404. doi: 10.1111/jch.v24.11
[4]	李春艳, 夏卿, 龙伟. 子痫前期联合筛查的研究进展[J]. 现代妇产科进展, 2022, 31(10):779-782.
[5]	Quessnsland Health. Quessnsland clinical guideline:hypretensive and pregency[EB/OL]. (2021-05-06)[2023-03-07]. https://www.health.qld.gov.au/__data/assets/pdf_file/0034/139948/g-hdp.pdf.
[6]	中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2020)[J]. 中华妇产科杂志, 2020, 55(4):227-238.
	Gestational Hypertension Disease Group of Obstetrics and Gynecology Branch of Chinese Medical Association. Diagnosis and treatment of hypertension and pre-eclampsia in pregnancy:a clinical practice guideline in China(2020)[J]. Chin J Obstet Gynecol, 2020, 55(4):227-238.
[7]	Dicenso A, Bayley L, Haynes RB. Accessing pre-appraised evidence:fine-tuning the 5S model into a 6S model[J]. Evid Based Nurs, 2009, 12(4):99-101. doi: 10.1136/ebn.12.4.99-b pmid: 19779069
[8]	韦当, 王聪尧, 肖晓娟, 等. 指南研究与评价(AGREEⅡ)工具实例解读[J]. 中国循证儿科杂志, 2013, 8(4):316-319.
	Wei D, Wang CY, Xiao XJ, et al. Interpretation of the tools of AGREEⅡ[J]. Chin J Evid Based Pediatr, 2013, 8(4):316-319.
[9]	Shea BJ, Hamel C, Wells GA, et al. AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews[J]. J Clin Epidemiol, 2009, 62(10):1013-1020. doi: 10.1016/j.jclinepi.2008.10.009 pmid: 19230606
[10]	胡雁, 郝玉芳. 循证护理学[M]. 2版. 北京: 人民卫生出版社, 2018:56-93.
[11]	庄云婷, 翟巾帼, 张莉, 等. 妊娠期孕妇下肢痉挛管理的最佳证据总结[J]. 中华护理杂志, 2022, 57(18):2276-2282.
	Zhuang YT, Zhai JG, Zhang L, et al. Best evidence summary for management of leg cramps during pregnancy in pregnant women[J]. Chin J Nurs, 2022, 57(18):2276-2282.
[12]	王春青, 胡雁. JBI证据预分级及证据推荐级别系统(2014版)[J]. 护士进修杂志, 2015, 30(11):964-967.
	Wang CQ, Hu Y. JBI evidence pre-classification and evidence recommendation level system(2014 edition)[J]. J Nurses Train, 2015, 30(11):964-967.
[13]	Phyllis A, Arun J. Preeclampsia:prevention[EB/OL]. (2023-01-03)[2023-03-07]. https://www.uptodate.cn/contents/zh-Hans/preeclampsia-prevention?search=%E5%AD%90%E7%97%AB%E5%89%8D%E6%9C%9F%E9%A2%84%E9%98%B2&source=search_result&selectedTitle=1-150&usage_type=default&display_rank=1.
[14]	Errol RN, Federica B. Early pregnancy prediction of preeclampsia[EB/OL]. (2022-06-28)[2023-03-07]. https://www.uptodate.cn/contents/early-pregnancy-prediction-of-preeclampsia?search= %E5%AD%90%E7%97%AB%E5%89%8D%E6%9C%9F%E9%A2%84%E9%98%B2&source=Out%20of%20date%20%20zh-Hans&selectedTitle=2-150.
[15]	Brown MA, Magee LA, Kenny LC, et al. Hypertensive disorders of pregnancy:ISSHP classification,diagnosis,and management recommendations for international practice[J]. Hypertension, 2018, 72(1):24-43. doi: 10.1161/HYPERTENSIONAHA.117.10803 pmid: 29899139
[16]	National Institute for Health and Care Excellence. Hypertension in pregnancy:diagnosis and management[EB/OL]. (2019-06-25)[2023-03-07]. https://www.nice.org.uk/guidance/ng133.
[17]	Spiro L, Scemons D. Management of chronic and gestational hypertension of pregnancy:a guide for primary care nurse practitioners[J]. Open Nurs J, 2018, 12:180-183. doi: 10.2174/1874434601812010180 pmid: 30258507
[18]	Poon LC, Shennan A, Hyett JA, et al. The International Federation of Gynecology and Obstetrics(FIGO) initiative on pre-eclampsia:a pragmatic guide for first-trimester screening and prevention[J]. Int J Gynaecol Obstet, 2019, 145(Suppl 1):1-33.
[19]	The American College of Obstetricians and Gynecologists. Gestational hypertension andpreeclampsia[EB/OL]. [2023-03-07]. https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2020/06/gestational-hypertension-and-preeclampsia.
[20]	Magee LA, Smith GN, Bloch C, et al. Guideline No.426:hypertensive disorders of pregnancy:diagnosis,prediction,prevention,and management[J]. J D’obstetrique Gynecol Du Can, 2022, 44(5):547-571.e1.
[21]	中华医学会心血管病学分会女性心脏健康学组, 中华医学会心血管病学分会高血压学组. 妊娠期高血压疾病血压管理专家共识(2019)[J]. 中华心血管病杂志, 2020, 48(3):195-204.
	Women’s Heart Health Group of Chinese Society of Cardiology of Chinese Medical Association, Hypertension Group of Chinese Society of Cardiology of Chinese Medical Association. Expert consensus on blood pressure management in hypertensive disorders of pregnancy(2019)[J]. Chin J Cardiol, 2020, 48(3):195-204.
[22]	中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期血压管理中国专家共识(2021)[J]. 中华妇产科杂志, 2021, 56(11):737-745.
	Hypertensive Disorders in Pregnancy Subgroup, Chinese Society of Obstetrics and Gynecology,Chinese Medical Association. Chinese expert consensus on blood pressure management during pregnancy[J]. Chin J Obstet Gynecol, 2021, 56(11):737-745.
[23]	中国妇幼保健协会妊娠合并糖尿病专业委员会, 中华医学会妇产科学分会产科学组. 妊娠期运动专家共识(草案)[J]. 中华围产医学杂志, 2021, 24(9):641-645.
	Professional Committee of Gestational Diabetes Mellitus, Chinese Maternal and Child Health Association, Obstetrics Subgroup,Society of Obstetrics and Gynecology,Chinese Medical Association. Expert consensus on exercise during pregnancy(draft)[J]. Chin J Perinat Med, 2021, 24(9):641-645.
[24]	Fogacci S, Fogacci F, Banach M, et al. Vitamin D supplementation and incident preeclampsia:a systematic review and meta-analysis of randomized clinical trials[J]. Clin Nutr, 2020, 39(6):1742-1752. doi: S0261-5614(19)33027-4 pmid: 31526611
[25]	Shay M, MacKinnon AL, Metcalfe A, et al. Depressed mood and anxiety as risk factors for hypertensive disorders of pregnancy:a systematic review and meta-analysis[J]. Psychol Med, 2020, 50(13):2128-2140. doi: 10.1017/S0033291720003062
[26]	Danielli M, Gillies C, Thomas RC, et al. Effects of supervised exercise on the development of hypertensive disorders of pregnancy:a systematic review and meta-analysis[J]. J Clin Med, 2022, 11(3):793. doi: 10.3390/jcm11030793
[27]	Gunabalasingam S, De Almeida Lima Slizys D, Quotah O, et al. Micronutrient supplementation interventions in preconception and pregnant women at increased risk of developing pre-eclampsia:a systematic review and meta-analysis[J]. Eur J Clin Nutr, 2023, 77(7):710-730. doi: 10.1038/s41430-022-01232-0
[28]	Abdelrahman MA, Osama H, Saeed H, et al. Impact of n-3 polyunsaturated fatty acid intake in pregnancy on maternal health and birth outcomes:systematic review and meta-analysis from randomized controlled trails[J]. Arch Gynecol Obstet, 2023, 307(1):249-262. doi: 10.1007/s00404-022-06533-0
[29]	Martínez-Vizcaíno V, Sanabria-Martínez G, Fernández-Rodríguez R, et al. Exercise during pregnancy for preventing gestational diabetes mellitus and hypertensive disorders:an umbrella review of randomised controlled trials and an updated meta-analysis[J]. BJOG, 2023, 130(3):264-275. doi: 10.1111/bjo.v130.3
[30]	Liu YH, Zhang YS, Chen JY, et al. Comparative effectiveness of prophylactic strategies for preeclampsia:a network meta-ana-lysis of randomized controlled trials[J]. Am J Obstet Gynecol, 2023, 228(5):535-546. doi: 10.1016/j.ajog.2022.10.014
[31]	李慧娟, 姚亮, 闫沛静, 等. 妊娠期钙补充预防先兆子痫的Meta分析[J]. 中国循证医学杂志, 2018, 18(10):1070-1079.
	Li HJ, Yao L, Yan PJ, et al. Meta-analysis of calcium supplementation during pregnancy to prevent preeclampsia[J]. Chin J Evid Based Med, 2018, 18(10):1070-1079.
[32]	Woo Kinshella ML, Sarr C, Sandhu A, et al. Calcium for pre-eclampsia prevention:a systematic review and network meta-analysis to guide personalised antenatal care[J]. BJOG, 2022, 129(11):1833-1843. doi: 10.1111/bjo.v129.11
[33]	Henderson JT, Vesco KK, Senger CA, et al. Aspirin use to prevent preeclampsia and related morbidity and mortality:updated evidence report and systematic review for the US preventive services task force[J]. JAMA, 2021, 326(12):1192-1206. doi: 10.1001/jama.2021.8551 pmid: 34581730
[34]	Duley L, Meher S, Hunter KE, et al. Antiplatelet agents for preventing pre-eclampsia and its complications[J]. Cochrane Database Syst Rev, 2019, 2019(10):CD004659.
[35]	Haugen M, Brantsæter AL, Winkvist A, et al. Associations of pre-pregnancy body mass index and gestational weight gain with pregnancy outcome and postpartum weight retention:a prospective observational cohort study[J]. BMC Pregnancy Childb, 2014, 14:201. doi: 10.1186/1471-2393-14-201
[36]	Wells GA, Shea B, Connell D, et al. The Newcastle Ottawa Scale(NOS) for assessing the quality of non-randomised studies in meta analyses[EB/OL]. (2014-01-02)[2023-11-08]. https://www.ohri.ca/Programs/clinical_epidemiology/default.asp.
[37]	Kalafat E, Benlioglu C, Thilaganathan B, et al. Home blood pres-sure monitoring in the antenatal and postpartum period:a systematic review meta-analysis[J]. Pregnancy Hypertens, 2020, 19:44-51. doi: S2210-7789(19)30473-8 pmid: 31901652
[38]	董彩霞, 荫士安. 中国孕妇营养与健康状况十年回顾[J]. 中华预防医学杂志, 2018, 52(1):94-100. doi: 10.3760/cma.j.issn.0253-9624.2018.01.019 pmid: 29334717
	Dong CX, Yin SA. The ten-year retrospect of nutrition and health status of pregnant women in China[J]. Chin J Prev Med, 2018, 52(1):94-100. doi: 10.3760/cma.j.issn.0253-9624.2018.01.019 pmid: 29334717
[39]	Vinogradov R, Smith VJ, Robson SC, et al. Informational needs related to aspirin prophylactic therapy amongst pregnant women at risk of preeclampsia:a qualitative study[J]. Pregnancy Hypertens, 2021, 25:161-168. doi: 10.1016/j.preghy.2021.06.006 pmid: 34147883
[40]	White C, Davis D. Barriers and enablers in maintaining healthy gestational weight gain:a qualitative study[J]. Women Birth, 2021, 34(5):e461-e467. doi: 10.1016/j.wombi.2020.09.009
[41]	Geissler KH, Evans V, Cooper MI, et al. Content analysis of patient-facing information related to preeclampsia[J]. Womens Health Issues, 2023, 33(1):77-86. doi: 10.1016/j.whi.2022.09.003